Livzon Pharmaceutical Group Inc. (HKG:1513)
Hong Kong · Delayed Price · Currency is HKD 39.50
+0.40 (1.02%)
Jul 28, 2025, 4:09 PM HKT
HKG:1513 Market Cap
HKG:1513 has a market cap or net worth of 39.17 billion as of July 28, 2025. Its market cap has increased by 17.92% in one year.
Market Cap
39.17B
Enterprise Value
32.79B
Revenue
12.60B
Ranking
n/a
PE Ratio
17.48
Stock Price
39.50
Market Cap Chart
Since July 14, 1997, HKG:1513's market cap has increased from 365.70M to 39.17B, an increase of 10,610.65%. That is a compound annual growth rate of 18.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 39.21B | 19.99% |
| Dec 31, 2024 | 32.67B | 4.83% |
| Dec 29, 2023 | 31.17B | 0.42% |
| Dec 30, 2022 | 31.04B | -21.73% |
| Dec 31, 2021 | 39.66B | 0.71% |
| Dec 31, 2020 | 39.38B | 27.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 271.47B |
| Hansoh Pharmaceutical Group Company | 215.83B |
| JD Health International | 155.85B |
| Innovent Biologics | 152.40B |
| Akeso | 135.17B |
| WuXi Biologics | 130.21B |
| Sino Biopharmaceutical | 129.66B |
| CSPC Pharmaceutical Group | 104.04B |